NERM
TMO icon

New England Research & Management’s Thermo Fisher Scientific TMO Stock Holding History

New England Research & Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
2,588
+1,175
+83% +$564K 0.51% 64
2026
Q1 		$695K Sell
1,413
-780
-36% -$423K 0.29% 88
2025
Q4 		$1.27M Sell
2,193
-210
-9% -$119K 0.56% 58
2025
Q3 		$1.17M Sell
2,403
-145
-6% -$67.5K 0.54% 67
2025
Q2 		$1.03M Buy
2,548
+567
+29% +$237K 0.49% 70
2025
Q1 		$986K Buy
1,981
+1,246
+170% +$675K 0.5% 66
2024
Q4 		$382K Sell
735
-1,480
-67% -$814K 0.19% 117
2024
Q3 		$1.37M Buy
2,215
+1,075
+94% +$636K 0.64% 57
2024
Q2 		$630K Buy
1,140
+540
+90% +$309K 0.3% 104
2024
Q1 		$349K Buy
+600
New +$337K 0.17% 133
2020
Q3 		– Sell
-2,125
Closed -$770K – 160
2020
Q2 		$770K Hold
2,125
– – 0.55% 70
2020
Q1 		$603K Buy
2,125
+475
+29% +$150K 0.51% 66
2019
Q4 		$536K Hold
1,650
– – 0.36% 94
2019
Q3 		$481K Buy
+1,650
New +$472K 0.35% 100

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

New England Research & Management's TMO Position: Q2 2026 in Review

New England Research & Management increased its Thermo Fisher Scientific (TMO) stake by 83% in Q2 2026, buying an estimated $564K and bringing the position to 2,588 shares worth $1.3M. The position accounts for 0.51% of the portfolio, ranked #64.

New England Research & Management first reported a position in TMO in Q3 2019 and has held it in 14 quarters since. The position peaked at $1.37M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New England Research & Management held 2,588 shares of Thermo Fisher Scientific worth $1.3M as of Q2 2026.
  • New England Research & Management bought 1,175 Thermo Fisher Scientific shares in Q2 2026, an estimated $564K.
  • Thermo Fisher Scientific made up 0.51% of New England Research & Management's portfolio in Q2 2026, its #64 holding.
  • New England Research & Management first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 14 quarters since.
  • New England Research & Management's Thermo Fisher Scientific position peaked at $1.37M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.